Codexis (CDXS) Debt Ratio (2017 - 2026)
Codexis' (CDXS) quarterly Debt Ratio came in at 0.31 in Q1 2026, up 38.19% year-on-year from 0.23 in Q1 2025, and up 15.32% quarter-over-quarter from 0.27 in Q4 2025.
Codexis (CDXS) Debt Ratio (2017 - 2026) Analysis & Trends
Codexis' Debt Ratio history runs 5 years deep, the most recent figure standing at 0.31 for Q1 2026.
- On a quarterly basis, Debt Ratio rose 38.19% year-over-year to 0.31 in Q1 2026; TTM through Mar 2026 was 0.31, a 38.19% increase from a year earlier, with the FY2025 full-year figure at 0.27, up 39.89% from the prior year.
- Debt Ratio improved to 0.31 in Q1 2026 per CDXS's latest filing, from 0.27 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.32 in Q3 2025 and bottomed at 0.19 in Q1 2024.
- The 3-year median for Debt Ratio is 0.23 (2025), against an average of 0.25.
- Biggest YoY gain for Debt Ratio was 65.88% in 2025; the steepest drop was 20.51% in 2025.
- Year by year, Debt Ratio stood at 0.19 in 2024, then soared by 39.89% to 0.27 in 2025, then climbed by 15.32% to 0.31 in 2026.
- Per Business Quant, the three latest CDXS Debt Ratio figures stand at 0.31 (Q1 2026), 0.27 (Q4 2025), and 0.32 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 1.41 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.11 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.05 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Codexis | 180.63 Mn | 115.49 Mn | 13.18 Mn | 0.31 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.31 |
| Dec 31, 2025 | 0.27 |
| Sep 30, 2025 | 0.32 |
| Jun 30, 2025 | 0.28 |
| Mar 31, 2025 | 0.23 |
| Dec 31, 2024 | 0.19 |
| Sep 30, 2024 | 0.19 |
| Jun 30, 2024 | 0.21 |
| Mar 31, 2024 | 0.19 |
| Sep 30, 2018 | 0.00 |
| Jun 30, 2018 | 0.00 |
| Mar 31, 2018 | 0.01 |
| Dec 31, 2017 | 0.01 |
| Sep 30, 2017 | 0.01 |
| Jun 30, 2017 | 0.01 |
| Mar 31, 2017 | 0.01 |